Hovione

Delox, founded in 2018 and based in Cascais, Portugal, specializes in the design and development of bio-decontamination devices aimed at creating clean and safe environments. As a spin-off from the Faculty of Sciences of the University of Lisbon, the company has developed innovative technologies, including DeloxHP, a solid formulation that safely releases concentrated hydrogen peroxide vapor. This advancement allows for the creation of compact and cost-effective bio-decontamination solutions, such as the Delox Box. Delox's applications span various sectors, including the sterilization of medical devices, bio-decontamination of laboratory equipment, and room decontamination in hospitals, the food industry, and even space environments. The company focuses on providing non-toxic solutions to combat microorganisms, ensuring safe handling and transportation of hydrogen peroxide through its cartridge system.

CellmAbs is a biotechnology company based in Lisbon, Portugal, that specializes in developing therapies focused on glycoimmunology and oncology. Established in 2019 as a spin-off from NOVA University of Lisbon, CellmAbs has received funding from prominent Life Science Venture Capital firms in Portugal. The company is dedicated to creating innovative solutions for cancer treatment, particularly through immunotherapies and glycobiology, and has developed several preclinical candidates aimed at targeting solid tumors. With a team of experienced professionals, CellmAbs is positioned for rapid growth in the biotech sector, leveraging its expertise in cancer-specific glycan targets.

CellmAbs is a biotechnology company based in Lisbon, Portugal, that specializes in developing therapies focused on glycoimmunology and oncology. Established in 2019 as a spin-off from NOVA University of Lisbon, CellmAbs has received funding from prominent Life Science Venture Capital firms in Portugal. The company is dedicated to creating innovative solutions for cancer treatment, particularly through immunotherapies and glycobiology, and has developed several preclinical candidates aimed at targeting solid tumors. With a team of experienced professionals, CellmAbs is positioned for rapid growth in the biotech sector, leveraging its expertise in cancer-specific glycan targets.

Delox, founded in 2018 and based in Cascais, Portugal, specializes in the design and development of bio-decontamination devices aimed at creating clean and safe environments. As a spin-off from the Faculty of Sciences of the University of Lisbon, the company has developed innovative technologies, including DeloxHP, a solid formulation that safely releases concentrated hydrogen peroxide vapor. This advancement allows for the creation of compact and cost-effective bio-decontamination solutions, such as the Delox Box. Delox's applications span various sectors, including the sterilization of medical devices, bio-decontamination of laboratory equipment, and room decontamination in hospitals, the food industry, and even space environments. The company focuses on providing non-toxic solutions to combat microorganisms, ensuring safe handling and transportation of hydrogen peroxide through its cartridge system.